Table 10 Aggregated payments – company-level data reported by companies following the JPMA Code
Company name | Standardised International Name recorded on drug company website | Value of aggregated payments (A & D & E) ($) | Aggregated payments—share of all payments (%) | Value of aggregated non-R&D payments (category D&E) ($) | Aggregated non-R&D payments (category D&E)—share of all payments (%) | Aggregated non-R&D payments (category D&E)—share of aggregated payments (%) | Value of aggregated non-R&D payments to HCPs (Category D—HCPs) ($) | Aggregated non-R&D payments to HCPs (Category D—HCPs)—share of all payments | Aggregated non-R&D payments to HCPs (Category D—HCPs)—share of aggregated non-R&D payments | Value of Aggregated payments (Category E—HCPs & HCOs) | Aggregated payments (Category E—HCPs & HCOs)—share of all payments | Aggregated payments (Category E—HCPs & HCOs)—share of aggregated payments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EA Pharma Co., Ltd., | EA Pharma | 17,413,922 | 83.14% | 17,413,922.10 | 83.14% | 100.00% | 16,934,873.19 | 80.85% | 97.25% | 479,048.91 | 2.29% | 2.75% |
CELGENE CORPORATION, | Celgene | 14,623,785 | 78.99% | 13,238,120.06 | 71.51% | 90.52% | 9,781,135.70 | 52.83% | 73.89% | 3,456,984.36 | 18.67% | 26.11% |
Shire Japan KK, | Shire Pharmaceuticals | 2,966,023 | 72.39% | 2,790,852.82 | 68.11% | 94.09% | 2,776,982.95 | 67.78% | 99.50% | 13,869.87 | 0.34% | 0.50% |
Kracie Pharma, Ltd | Kracie Pharma | 3,582,579 | 71.79% | 3,581,678.14 | 71.77% | 99.97% | 3,262,506.69 | 65.38% | 91.09% | 319,171.45 | 6.40% | 8.91% |
Mylan EPD G.K | Mylan | 6,520,184 | 70.40% | 6,520,183.79 | 70.40% | 100.00% | 6,326,172.06 | 68.30% | 97.02% | 194,011.73 | 2.09% | 2.98% |
TOA EIYO LTD, | Toa Eiyo | 3,508,745 | 69.79% | 3,435,278.29 | 68.33% | 97.91% | 2,627,617.59 | 52.27% | 76.49% | 807,660.70 | 16.07% | 23.51% |
Taisho Toyama Pharmaceutical Co Ltd | Taisho Toyama Pharmaceutical | 16,597,647 | 68.98% | 16,597,120.42 | 68.97% | 100.00% | 15,342,534.76 | 63.76% | 92.44% | 1,254,585.66 | 5.21% | 7.56% |
Otsuka Pharmaceutical Factory, Inc | Otsuka Pharmaceutical Factory | 6,884,704 | 66.78% | 6,877,315.57 | 66.71% | 99.89% | 6,592,638.08 | 63.95% | 95.86% | 284,677.49 | 2.76% | 4.14% |
NIHON PHARMACEUTICAL CO., LTD., | Nihon Pharmaceutical | 3,759,253 | 64.89% | 2,509,810.90 | 43.32% | 66.76% | 2,362,612.60 | 40.78% | 94.14% | 147,198.30 | 2.54% | 5.86% |
Maruishi Pharmaceutical Co., Ltd., | Maruishi Pharmaceutical | 2,343,468 | 63.02% | 2,303,006.16 | 61.93% | 98.27% | 2,289,985.76 | 61.58% | 99.43% | 13,020.40 | 0.35% | 0.57% |
KOWA PHARMACEUTICAL COMPANY LTD | Kowa Pharmaceuticals | 15,077,379 | 62.98% | 15,077,379.35 | 62.98% | 100.00% | 13,062,422.28 | 54.57% | 86.64% | 2,014,957.07 | 8.42% | 13.36% |
TSUMURA & CO., | Tsumura | 18,435,580 | 61.85% | 18,435,580.08 | 61.85% | 100.00% | 18,054,929.32 | 60.57% | 97.94% | 380,650.76 | 1.28% | 2.06% |
Meiji Seika Pharma Co., Ltd., | Meiji Seika Pharma | 14,380,059 | 60.27% | 9,283,129.91 | 38.91% | 64.56% | 8,217,558.56 | 34.44% | 88.52% | 1,065,571.35 | 4.47% | 11.48% |
Kissei Pharmaceutical Co., Ltd., | Kissei Pharmaceutical | 14,024,145 | 60.13% | 12,360,144.23 | 53.00% | 88.13% | 10,361,946.51 | 44.43% | 83.83% | 1,998,197.72 | 8.57% | 16.17% |
Biofermin Pharmaceutical Co., Ltd | Biofermin Pharmaceutical | 275,192 | 58.48% | 275,192.21 | 58.48% | 100.00% | 252,229.91 | 53.60% | 91.66% | 22,962.30 | 4.88% | 8.34% |
Pfizer Japan Inc., | Pfizer | 58,456,238 | 54.88% | 58,088,767.18 | 54.53% | 99.37% | 57,599,771.22 | 54.07% | 99.16% | 488,995.96 | 0.46% | 0.84% |
FUJIFILM Toyama Chemical Co., Ltd | FUJIFILM Toyama Chemical | 2,118,662 | 53.82% | 1,874,576.16 | 47.62% | 88.48% | 937,288.08 | 23.81% | 50.00% | 937,288.08 | 23.81% | 50.00% |
Takeda Pharmaceutical Company Limited., | Takeda | 63,042,432 | 53.71% | 63,042,432.07 | 53.71% | 100.00% | 62,259,597.55 | 53.04% | 98.76% | 782,834.52 | 0.67% | 1.24% |
KYORIN Pharmaceutical Co., Ltd., | Kyorin Pharmaceutical | 10,720,914 | 52.77% | 10,628,868.04 | 52.32% | 99.14% | 10,024,752.71 | 49.35% | 94.32% | 604,115.33 | 2.97% | 5.68% |
Bristol-Myers Squibb K.K, | Bristol-Myers Squibb | 29,971,754 | 50.18% | 29,388,030.74 | 49.20% | 98.05% | 29,023,493.46 | 48.59% | 98.76% | 364,537.28 | 0.61% | 1.24% |
AYUMI Pharmaceutical Corporation, | AYUMI Pharmaceutical | 2,023,069 | 49.73% | 2,023,069.23 | 49.73% | 100.00% | 1,977,970.68 | 48.62% | 97.77% | 45,098.55 | 1.11% | 2.23% |
Santen Pharmaceutical Co., Ltd., | Santen Pharmaceutical | 10,179,708 | 49.29% | 9,969,835.96 | 48.27% | 97.94% | 9,642,725.64 | 46.69% | 96.72% | 327,110.32 | 1.58% | 3.28% |
BEE BRAND MEDICO DENTAL.Co.,Ltd | Bee Brand Medico Dental | 19,795 | 48.66% | 19,622.78 | 48.24% | 99.13% | 18,918.67 | 46.51% | 96.41% | 704.11 | 1.73% | 3.59% |
Wakamoto Pharmaceutical Co., Ltd., | Wakamoto Pharmaceutical | 2,244,556 | 48.06% | 312,400.00 | 6.69% | 13.92% | 296,499.89 | 6.35% | 94.91% | 15,900.11 | 0.34% | 5.09% |
Novartis Pharma K.K., | Novartis | 46,059,783 | 46.80% | 44,474,637.68 | 45.19% | 96.56% | 43,949,275.36 | 44.66% | 98.82% | 525,362.32 | 0.53% | 1.18% |
DAIICHI SANKYO COMPANY, LIMITED., | Daiichi Sankyo | 96,159,420 | 46.36% | 96,096,014.49 | 46.33% | 99.93% | 94,574,275.36 | 45.60% | 98.42% | 1,521,739.13 | 0.73% | 1.58% |
Eisai Co., Ltd., | Eisai | 42,690,217 | 45.55% | 35,452,898.55 | 37.83% | 83.05% | 33,958,333.33 | 36.24% | 95.78% | 1,494,565.22 | 1.59% | 4.22% |
Torii Pharmaceutical Co., Ltd., | Torii Pharmaceutical | 7,665,201 | 45.31% | 7,199,367.81 | 42.55% | 93.92% | 6,397,904.66 | 37.81% | 88.87% | 801,463.15 | 4.74% | 11.13% |
TEIJIN PHARMA LIMITED., | Teijin Pharma | 12,028,670 | 45.15% | 12,028,670.28 | 45.15% | 100.00% | 11,579,067.71 | 43.46% | 96.26% | 449,602.57 | 1.69% | 3.74% |
Kyowa Hakko Kirin Company, Limited, | Kyowa Kirin | 32,108,834 | 44.71% | 32,108,834.48 | 44.71% | 100.00% | 30,100,019.44 | 41.92% | 93.74% | 2,008,815.04 | 2.80% | 6.26% |
ZERIA Pharmaceutical Co., Ltd., | Zeria Pharmaceutical | 3,308,774 | 44.55% | 3,308,774.35 | 44.55% | 100.00% | 3,108,254.69 | 41.85% | 93.94% | 200,519.66 | 2.70% | 6.06% |
Otsuka Pharmaceutical Co., Ltd., | Otsuka Pharmaceuticals | 48,269,344 | 44.15% | 48,269,344.24 | 44.15% | 100.00% | 45,835,694.77 | 41.92% | 94.96% | 2,433,649.47 | 2.23% | 5.04% |
MOCHIDA PHARMACEUTICAL CO., LTD., | Mochida Pharmaceutical | 11,897,575 | 44.02% | 11,897,575.13 | 44.02% | 100.00% | 11,197,795.26 | 41.43% | 94.12% | 699,779.87 | 2.59% | 5.88% |
POLA-Pharma., | Pola Pharma | 1,184,913 | 43.94% | 1,183,855.95 | 43.90% | 99.91% | 1,103,215.32 | 40.91% | 93.19% | 80,640.63 | 2.99% | 6.81% |
MSD K.K., | Merck Sharp & Dohme | 46,779,000 | 43.24% | 46,779,000.07 | 43.24% | 100.00% | 46,145,657.57 | 42.66% | 98.65% | 633,342.50 | 0.59% | 1.35% |
Fuso Pharmaceutical Industries, Ltd., | Fuso Pharmaceutical Industries | 1,001,214 | 43.02% | 1,001,213.99 | 43.02% | 100.00% | 859,742.25 | 36.94% | 85.87% | 141,471.74 | 6.08% | 14.13% |
Janssen Pharmaceutical K.K., | Janssen Pharmaceuticals | 17,626,105 | 42.36% | 13,342,653.98 | 32.06% | 75.70% | 13,201,639.49 | 31.73% | 98.94% | 141,014.49 | 0.34% | 1.06% |
Astellas Pharma Inc., | Astellas Pharma | 45,407,609 | 42.29% | 42,110,507.24 | 39.22% | 92.74% | 42,074,275.36 | 39.19% | 99.91% | 36,231.88 | 0.03% | 0.09% |
Alfresa Pharma Corporation | Alfresa Pharma | 789,557 | 40.88% | 789,557.18 | 40.88% | 100.00% | 760,764.52 | 39.39% | 96.35% | 28,792.66 | 1.49% | 3.65% |
Sanofi K.K., | Sanofi | 21,834,459 | 39.34% | 21,834,459.30 | 39.34% | 100.00% | 21,785,766.29 | 39.25% | 99.78% | 48,693.01 | 0.09% | 0.22% |
Bayer Yakuhin, Ltd., | Bayer | 26,629,090 | 39.10% | 26,629,090.02 | 39.10% | 100.00% | 25,870,326.41 | 37.99% | 97.15% | 758,763.61 | 1.11% | 2.85% |
Eli Lilly Japan K.K., | Eli Lilly | 47,449,666 | 38.45% | 46,777,425.98 | 37.90% | 98.58% | 46,414,707.45 | 37.61% | 99.22% | 362,718.53 | 0.29% | 0.78% |
TAIHO PHARMACEUTICAL CO., LTD., | Taiho Pharmaceutical | 19,423,820 | 38.35% | 16,964,923.77 | 33.50% | 87.34% | 15,584,041.93 | 30.77% | 91.86% | 1,380,881.84 | 2.73% | 8.14% |
Sumitomo Dainippon Pharma Co., Ltd., | Sumitomo Dainippon Pharma | 23,679,188 | 37.88% | 20,925,766.86 | 33.48% | 88.37% | 19,537,706.79 | 31.26% | 93.37% | 1,388,060.07 | 2.22% | 6.63% |
Nippon Boehringer Ingelheim Co., Ltd., | Boehringer Ingelheim | 41,288,043 | 37.61% | 41,288,043.48 | 37.61% | 100.00% | 41,089,311.60 | 37.42% | 99.52% | 198,731.88 | 0.18% | 0.48% |
Maruho Co., Ltd., | Maruho | 14,461,866 | 37.54% | 14,461,865.66 | 37.54% | 100.00% | 14,040,456.29 | 36.45% | 97.09% | 421,409.37 | 1.09% | 2.91% |
TOYAMA CHEMICAL CO., LTD., | Toyama Chemical | 939,531 | 36.74% | 66,948.24 | 2.62% | 7.13% | 63,923.69 | 2.50% | 95.48% | 3,024.55 | 0.12% | 4.52% |
Nippon Chemiphar Co., Ltd., | Nippon Chemiphar | 868,502 | 36.57% | 868,501.90 | 36.57% | 100.00% | 649,543.15 | 27.35% | 74.79% | 218,958.75 | 9.22% | 25.21% |
ASAHI KASEI PHARMA CORPORATION, | Asahi Kasei Pharma | 15,323,641 | 36.42% | 15,323,641.30 | 36.42% | 100.00% | 14,504,673.91 | 34.47% | 94.66% | 818,967.39 | 1.95% | 5.34% |
Nippon Zoki Pharmaceutical Cp., Ltd., | Nippon Zoki | 2,623,265 | 36.32% | 2,621,573.48 | 36.29% | 99.94% | 2,567,429.69 | 35.54% | 97.93% | 54,143.79 | 0.75% | 2.07% |
Yakult Honsha Company, Limited., | Yakult Honsha | 3,967,391 | 36.20% | 3,958,333.33 | 36.12% | 99.77% | 3,894,927.53 | 35.54% | 98.40% | 63,405.80 | 0.58% | 1.60% |
ASKA Pharmaceutical Co., Ltd | ASKA Pharmaceutical | 4,306,431 | 34.17% | 4,306,431.16 | 34.17% | 100.00% | 4,052,943.84 | 32.16% | 94.11% | 253,487.32 | 2.01% | 5.89% |
Hisamitsu Pharmaceutical Co., Inc., | Hisamitsu Pharmaceutical | 10,572,249 | 33.96% | 10,572,248.75 | 33.96% | 100.00% | 9,938,856.72 | 31.93% | 94.01% | 633,392.03 | 2.03% | 5.99% |
Novo Nordisk Pharma Ltd., | Novo Nordisk | 10,852,882 | 33.89% | 10,852,882.05 | 33.89% | 100.00% | 10,741,762.68 | 33.55% | 98.98% | 111,119.37 | 0.35% | 1.02% |
FUJIFILM RI Pharma, Co, Ltd | FUJIFILM RI Pharma | 1,306,961 | 33.37% | 1,003,295.82 | 25.62% | 76.77% | 983,575.85 | 25.11% | 98.03% | 19,719.97 | 0.50% | 1.97% |
Mitsubishi Tanabe Pharma Corporation, | Mitsubishi Tanabe Pharma | 36,521,739 | 33.17% | 36,521,739.14 | 33.17% | 100.00% | 34,048,913.05 | 30.92% | 93.23% | 2,472,826.09 | 2.25% | 6.77% |
KM Biologics Co., Ltd | KM Biologics | 921,668 | 32.45% | 460,786.59 | 16.22% | 49.99% | 458,519.94 | 16.14% | 99.51% | 2,266.65 | 0.08% | 0.49% |
AbbVie GK, | AbbVie | 16,981,345 | 32.39% | 16,562,567.82 | 31.59% | 97.53% | 15,810,942.72 | 30.16% | 95.46% | 751,625.10 | 1.43% | 4.54% |
TERUMO CORPORATION, | Terumo Corporation | 6,923,109 | 32.34% | 6,917,581.52 | 32.31% | 99.92% | 6,290,380.43 | 29.38% | 90.93% | 627,201.09 | 2.93% | 9.07% |
GlaxoSmithKline K.K., | GlaxoSmithKline | 13,906,467 | 31.85% | 13,906,467.39 | 31.85% | 100.00% | 13,751,005.43 | 31.49% | 98.88% | 155,461.96 | 0.36% | 1.12% |
Merck Serono Co., Ltd., | Merck Serono | 2,937,777 | 30.99% | 2,937,776.53 | 30.99% | 100.00% | 2,937,776.53 | 30.99% | 100.00% | 0.00 | 0.00% | 0.00% |
EN Otsuka Pharmaceutical Co., Ltd | EN Otsuka Pharmaceutical Company | 71,257 | 30.58% | 71,257.32 | 30.58% | 100.00% | 66,079.05 | 28.36% | 92.73% | 5,178.27 | 2.22% | 7.27% |
Nippon Kayaku Co., Ltd | Nippon Kayaku | 2,812,512 | 30.34% | 2,812,512.05 | 30.34% | 100.00% | 2,587,808.83 | 27.92% | 92.01% | 224,703.22 | 2.42% | 7.99% |
Chugai Pharmaceutical Co., Ltd., | Chugai Pharmaceutical | 41,071,879 | 29.35% | 41,071,879.46 | 29.35% | 100.00% | 39,528,055.44 | 28.25% | 96.24% | 1,543,824.02 | 1.10% | 3.76% |
Asahi Kasei Medical Co.,Ltd | Asahi Kasei Medical | 468,089 | 29.07% | 444,990.95 | 27.64% | 95.07% | 294,257.25 | 18.28% | 66.13% | 150,733.70 | 9.36% | 33.87% |
Kaken Pharmaceutical Co., Ltd., | Kaken Pharmaceutical | 6,171,882 | 28.28% | 6,131,466.27 | 28.09% | 99.35% | 5,607,744.07 | 25.69% | 91.46% | 523,722.20 | 2.40% | 8.54% |
AstraZeneca K.K., | AstraZeneca | 22,176,141 | 28.23% | 22,176,140.67 | 28.23% | 100.00% | 22,169,956.30 | 28.22% | 99.97% | 6,184.37 | 0.01% | 0.03% |
UCB Japan Co., Ltd., | UCB Pharma | 3,123,206 | 27.10% | 2,975,907.14 | 25.82% | 95.28% | 2,906,786.32 | 25.22% | 97.68% | 69,120.82 | 0.60% | 2.32% |
NIPPON SHINYAKU CO., LTD., | Nippon Shinyaku | 5,801,649 | 26.29% | 5,776,574.34 | 26.18% | 99.57% | 5,277,143.88 | 23.91% | 91.35% | 499,430.46 | 2.26% | 8.65% |
Senju Pharmaceutical Co., Ltd | Senju Pharmaceutical | 5,148,426 | 25.33% | 5,126,615.46 | 25.22% | 99.58% | 4,822,323.58 | 23.73% | 94.06% | 304,291.88 | 1.50% | 5.94% |
Shionogi & Co,. Ltd., | Shionogi | 10,643,116 | 23.68% | 9,981,884.05 | 22.21% | 93.79% | 9,673,913.04 | 21.52% | 96.91% | 307,971.01 | 0.69% | 3.09% |
ONO PHARMACEUTICAL CO., LTD., | Ono Pharmaceutical | 36,116,877 | 22.99% | 36,116,877.29 | 22.99% | 100.00% | 35,193,555.22 | 22.40% | 97.44% | 923,322.07 | 0.59% | 2.56% |
Biogen Japan, Ltd | Biogen | 2,661,488 | 22.84% | 2,661,487.57 | 22.84% | 100.00% | 2,578,023.89 | 22.12% | 96.86% | 83,463.68 | 0.72% | 3.14% |
Minophagen Pharmaceutical Co., | Minophagen Pharmaceutical | 117,047 | 22.23% | 102,494.47 | 19.47% | 87.57% | 98,727.13 | 18.75% | 96.32% | 3,767.34 | 0.72% | 3.68% |
Toray Industries, Inc., | Toray Industries | 671,091 | 21.99% | 317,852.06 | 10.41% | 47.36% | 266,172.20 | 8.72% | 83.74% | 51,679.86 | 1.69% | 16.26% |
SANWA KAGAKU KENKYUSHO CO., LTD., | Sanwa Kagaku Kenkyusho | 3,373,423 | 18.57% | 3,373,423.43 | 18.57% | 100.00% | 3,303,505.77 | 18.18% | 97.93% | 69,917.66 | 0.38% | 2.07% |
Kyoto Pharmaceutical Industries, Ltd | Kyoto Pharmaceutical Industries | 7,541 | 11.82% | 7,540.93 | 11.82% | 100.00% | 0.00 | 0.00% | 0.00% | 7,540.93 | 11.82% | 100.00% |
Fujimoto Pharmaceutical Corporation, | Fujimoto Pharmaceutical Corporation | 194,381 | 11.76% | 194,325.65 | 11.75% | 99.97% | 175,697.58 | 10.63% | 90.41% | 18,628.07 | 1.13% | 9.59% |
Taisho Pharmaceutical Co., Ltd., | Taisho Pharmaceutical | 837,051 | 7.50% | 77,541.10 | 0.69% | 9.26% | 69,191.95 | 0.62% | 89.23% | 8,349.15 | 0.07% | 10.77% |
The Research Foundation for Microbial Diseases of Osaka University | The Research Foundation For Microbial Diseases of Osaka University | 73,024 | 1.36% | 69,122.31 | 1.29% | 94.66% | 55,076.16 | 1.03% | 79.68% | 14,046.15 | 0.26% | 20.32% |
Teikoku Seiyaku Co., Ltd., | Teikoku Seiyaku | 34,602 | 0.83% | 34,602.49 | 0.83% | 100.00% | 27,826.58 | 0.67% | 80.42% | 6,775.91 | 0.16% | 19.58% |
SEIKAGAKU CORPORATION, | Seikagaku Corporation | 51,634 | 0.41% | 43,530.90 | 0.35% | 84.31% | 39,760.64 | 0.32% | 91.34% | 3,770.26 | 0.03% | 8.66% |
Kowa Company. Ltd., | Kowa Company | 50,991 | 0.26% | 49,825.33 | 0.25% | 97.71% | 41,897.97 | 0.21% | 84.09% | 7,927.36 | 0.04% | 15.91% |
Japan Tobacco Inc., | Japan Tobacco | 19,526 | 0.08% | 19,526.21 | 0.08% | 100.00% | 0.00 | 0.00% | 0.00% | 19,526.21 | 0.08% | 100.00% |
Otsuka Holdings Co., Ltd | Otsuka Holdings | 0 | 0.00% | 0.00 | 0.00% | 0.00% | 0.00 | 0.00% | 0.00% | 0.00 | 0.00% | 0.00% |
Alcon Pharmaceuticals Ltd | Alcon | 0 | 0.00% | 0.00 | 0.00% | 0.00% | 0.00 | 0.00% | 0.00% | 0.00 | 0.00% | 0.00% |